These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2997653)

  • 1. Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists in the rat.
    Cooper SJ; Moores WR; Jackson A; Barber DJ
    Neuropharmacology; 1985 Sep; 24(9):877-83. PubMed ID: 2997653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads.
    Jackson A; Cooper SJ
    Brain Res Bull; 1985 Oct; 15(4):391-6. PubMed ID: 2998563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of opioid receptor sub-types in tifluadom-induced feeding.
    Jackson HC; Sewell RD
    J Pharm Pharmacol; 1984 Oct; 36(10):683-6. PubMed ID: 6150086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat.
    Jackson A; Cooper SJ
    Psychopharmacology (Berl); 1988; 94(2):248-53. PubMed ID: 2895484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S; Bhargava HN
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
    Cooper SJ; Jackson A; Kirkham TC
    Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioid agonists and antagonists: effects on drinking and urinary output.
    Leander JD
    Appetite; 1984 Mar; 5(1):7-14. PubMed ID: 6091543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A; Kelly A
    Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlordiazepoxide-induced hyperphagia in non-food-deprived rats: effects of Ro15-1788, CGS 8216 and ZK 93 426.
    Cooper SJ; Moores WR
    Eur J Pharmacol; 1985 May; 112(1):39-45. PubMed ID: 3926515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
    Schmauss C
    Eur J Pharmacol; 1987 Jun; 137(2-3):197-205. PubMed ID: 2886350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kappa opioid receptor and food intake.
    Morley JE; Levine AS; Kneip J; Grace M; Zeugner H; Shearman GT
    Eur J Pharmacol; 1985 May; 112(1):17-25. PubMed ID: 2990965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):334-42. PubMed ID: 1309877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats.
    Ramarao P; Bhargava HN
    Pharmacol Biochem Behav; 1989 Jun; 33(2):375-80. PubMed ID: 2554341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
    Leander JD; Hart JC; Zerbe RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.